JP2019502719A5 - - Google Patents

Download PDF

Info

Publication number
JP2019502719A5
JP2019502719A5 JP2018536488A JP2018536488A JP2019502719A5 JP 2019502719 A5 JP2019502719 A5 JP 2019502719A5 JP 2018536488 A JP2018536488 A JP 2018536488A JP 2018536488 A JP2018536488 A JP 2018536488A JP 2019502719 A5 JP2019502719 A5 JP 2019502719A5
Authority
JP
Japan
Prior art keywords
group
nociception
corneal nociception
patient
corneal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536488A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019502719A (ja
JP6752439B2 (ja
Filing date
Publication date
Priority claimed from US15/006,085 external-priority patent/US9827225B2/en
Application filed filed Critical
Publication of JP2019502719A publication Critical patent/JP2019502719A/ja
Publication of JP2019502719A5 publication Critical patent/JP2019502719A5/ja
Application granted granted Critical
Publication of JP6752439B2 publication Critical patent/JP6752439B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536488A 2016-01-25 2017-01-24 眼表面の侵害受容を処置するためのプロスタサイクリンアンタゴニストの使用 Active JP6752439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/006,085 2016-01-25
US15/006,085 US9827225B2 (en) 2016-01-25 2016-01-25 Use of prostacyclin antagonists for treating ocular surface nociception
PCT/US2017/014677 WO2017132115A1 (en) 2016-01-25 2017-01-24 Use of prostacyclin antagonists for treating ocular surface nociception

Publications (3)

Publication Number Publication Date
JP2019502719A JP2019502719A (ja) 2019-01-31
JP2019502719A5 true JP2019502719A5 (enExample) 2020-02-27
JP6752439B2 JP6752439B2 (ja) 2020-09-09

Family

ID=59360031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536488A Active JP6752439B2 (ja) 2016-01-25 2017-01-24 眼表面の侵害受容を処置するためのプロスタサイクリンアンタゴニストの使用

Country Status (10)

Country Link
US (4) US9827225B2 (enExample)
EP (1) EP3407975B1 (enExample)
JP (1) JP6752439B2 (enExample)
KR (1) KR20180104108A (enExample)
CN (1) CN108883307B (enExample)
AU (1) AU2017212343B2 (enExample)
CA (1) CA3012197A1 (enExample)
ES (1) ES2894916T3 (enExample)
MX (1) MX379497B (enExample)
WO (1) WO2017132115A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9827225B2 (en) * 2016-01-25 2017-11-28 Jenivision Inc. Use of prostacyclin antagonists for treating ocular surface nociception
JOP20210217A1 (ar) * 2019-02-15 2023-01-30 Novartis Ag طرق لعلاج ألم سطح عين
JP2024506872A (ja) * 2021-02-05 2024-02-15 ジェニヴィジョン インク. Ep2受容体アゴニストの眼窩周囲投与のための組成物および方法
AU2022239568A1 (en) * 2021-03-18 2023-10-05 Jenivision Inc. Methods and compositions for treating eye diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
NZ331480A (en) * 1997-09-04 2000-02-28 F 2-(Arylphenyl)amino-imidazoline derivatives and pharmaceutical compositions
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
IL155436A0 (en) * 2000-11-14 2003-11-23 Hoffmann La Roche Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
JP2006525254A (ja) * 2003-05-01 2006-11-09 エフ.ホフマン−ラ ロシュ アーゲー Ipアンタゴニストとしてのイミダゾリン−2−イルアミノ−フェニルアミド類
US9610990B2 (en) * 2009-05-08 2017-04-04 Titan Trailers Inc. Apparatus and method for warming the floor of a trailer
CA2860392C (en) * 2011-12-21 2016-08-30 Allergan, Inc. Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
US9321745B2 (en) 2013-03-12 2016-04-26 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid IP receptors
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
US9827225B2 (en) 2016-01-25 2017-11-28 Jenivision Inc. Use of prostacyclin antagonists for treating ocular surface nociception

Similar Documents

Publication Publication Date Title
CN102811610B (zh) 无刺激性眼科聚维酮碘组合物
POST et al. Demodex folliculorum and blepharitis
JP2019534867A5 (enExample)
JP2019089849A5 (enExample)
JP2019536784A5 (enExample)
JP2019502719A5 (enExample)
JP2018529693A5 (enExample)
JP2019532931A (ja) 眼瞼炎の治療に使用するための医薬組成物
RU2018114926A (ru) Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
CN119546278A (zh) 两性离子在眼用局部乳膏组合物和制剂中的新应用
JP6014033B2 (ja) 防腐剤無添加ビマトプロストおよびチモロール溶液
CH711969A2 (it) Composizione per il trattamento della presbiopia.
JP2017520527A5 (enExample)
RU2017145545A (ru) Терапевтическое средство против сухости глаз, характеризуемое нанесением на глаза пациентов с сухостью глаз, носящих гибкие контактные линзы
JP2018528169A5 (enExample)
JP2020531511A5 (enExample)
EA201300314A1 (ru) Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство
JP2013534527A (ja) コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物
JP6871400B2 (ja) 眼表面疾患の治療のための製剤および関連方法
WO2010075315A2 (en) Topical formulations of flap inhibitors for administration to an eye
JP2017527600A5 (enExample)
CN103841968A (zh) 眼睑治疗方法
RU2017111579A (ru) Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина
JP2017533228A5 (enExample)
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.